Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals. Latest publications include:

• How I treat chronic myeloid leukemia in children and adolescents
  (Hijiya N et al. Blood, March 2019) (epub ahead of print)
• Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study
  (de Bruijn CMA et al. Br J Hematol, March 2019)
  (epub ahead of print)
• Dasatinib: A review in pediatric chronic myeloid leukemia
  (McCafferty EH et al. Paediatr Drugs, November 2018)
  (epub ahead of print)
  
• Real-life management of children and adolescents with chronic myeloid leukemia: The Italian experience
  (Giona F et al. Acta Haematol, September 2018)
  (epub ahead of print)
  
• Generic formulation of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients
  (Suttorp M et al. Pediatr Blood Cancer, August 2018)
  (epub ahead of print)

Search here for more publications on pediatric CML